Friday, December 4, 2020
Urdu Web Newspaper 92news Live(UK) 92news Live(PK)
Urdu Web Newspaper
92news Live(UK) 92news Live(PK)

Coronavirus vaccine nationalism 'will not help us': WHO

Coronavirus vaccine nationalism 'will not help us': WHO
August 7, 2020
GENEVA (AFP) - The World Health Organisation (WHO) warned Friday that "vaccine nationalism" will not save the world, stating that rich countries who do come up with a vaccine for coronavirus will not be able to benefit by hogging it and keeping the anecdote from poor nations.  WHO chief Tedros Adhanom Ghebreyesus said it would be in wealthier nations' interests to ensure that any vaccines eventually produced to protect against the new coronavirus were shared globally. "Vaccine nationalism is not good, it will not help us," Tedros told the Aspen Security Forum in the United States, via video-link from the WHO''s headquarters in Geneva. "For the world to recover faster, it has to recover together, because it's a globalised world: the economies are intertwined. Part of the world or a few countries cannot be a safe haven and recover. "The damage from COVID-19 could be less when those countries who have the funding commit to this," he said. He said the existence of the deadly respiratory disease anywhere put lives and livelihoods at risk everywhere. "They are not giving charity to others: they are doing it for themselves, because when the rest of the world recovers and opens up, they also benefit."

The race for the COVID-19 vaccine

The United Nations health agency also said that multiple different types of vaccines would likely be needed to combat COVID-19. Twenty-six candidate vaccines are in various stages of being tested on humans, with six having reached Phase 3 wider levels of clinical trials. "Phase 3 doesn't mean nearly there," explained the WHO's emergencies director Michael Ryan. "Phase 3 means this is the first time this vaccine has been put into the general population, into otherwise healthy individuals, to see if the vaccine will protect them against natural infection. "We've got a good range of products across a number of different platforms, across a number of different countries," he said of the leading candidate vaccines, which use different methods to provide immunity. However, "there's no guarantee that any of these six will give us the answer -- and we probably will need more than one vaccine to do this job."

Contact Details